SYN-4,SYN-9-DIMETHYLUNDECACYCLO-[9.9.0.0(1,5).0(2,12).0(2,18).0(3,7).0(6,10).0(8,12).0(11,15).0(13,17).0(16,20)]-ICOSANE
Compound with spectra: 1 NMR
![SYN-4,SYN-9-DIMETHYLUNDECACYCLO-[9.9.0.0(1,5).0(2,12).0(2,18).0(3,7).0(6,10).0(8,12).0(11,15).0(13,17).0(16,20)]-ICOSANE](/api/compound/ACMfAcZJMGo.png?ph=true&h=300&w=458 "SYN-4,SYN-9-DIMETHYLUNDECACYCLO-[9.9.0.0(1,5).0(2,12).0(2,18).0(3,7).0(6,10).0(8,12).0(11,15).0(13,17).0(16,20)]-ICOSANE")
| SpectraBase Compound ID | ACMfAcZJMGo |
|---|---|
| InChI | InChI=1S/C22H24/c1-5-15-13-14-16(5)20-8-3-7-11-9-4-10(12(8)11)22(20)18(14)6(2)17(13)21(9,22)19(7,15)20/h5-18H,3-4H2,1-2H3/t5-,6+,7?,8?,9?,10?,11?,12?,13?,14?,15?,16?,17?,18?,19?,20?,21?,22? |
| InChIKey | SCNPUPQVWXVIGP-CATGMFTNSA-N |
| Mol Weight | 288.43 g/mol |
| Molecular Formula | C22H24 |
| Exact Mass | 288.187801 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
13,15,17,20-TETRAOXADECACYCLO-[8.8.1.1(12,18).0(1,11).0(2,6).0(4,11).0(5,9).0(7,19).0(10,14).0(16,19)]-ICOSANE
NORALPINDENOSIDE_B
LUTEOLIN-7-O-[2-(BETA-D-APIOFURANOSYL)-4-(BETA-D-GLUCOPYRANOSYL)-6-MALONYL]-BETA-D-GLUCOPYRANOSIDE
N,N-Dibenzyl-14,19-dihydroxyundecacyclo-icosane-4,9-dicarboxamide
11,24-DIOXATRIDECACYCLO-[13.11.0.0(1,21).0(2,6).0(4,12).0(5,9).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20).0(22,26).0(23,25)]-HEXACOSANE
(E)-9-(3,4,5-Trimethoxybenzylidene)-5-(3,4,5-trimethoxyphenyl)-3-methyl-6,7,8,9-tetrahydro-5H-thiazolo[2,3-b]quinazoline
13, 14-seco-8,22-cyclo-lanost-5(6), 24(25)-dien
JPZBRWDQKBCQJI-UHFFFAOYSA-N
Heptacyclo(8.5.1.0/2,9/.0/3,8/,.0/3,14/.0/8,12/.0/11,15/)hexadecane
QUERCETIN-7-O-BETA-D-GLUCOPYRANOSYL-[(1->6)-ALPHA-L-RHAMNOPYRANOSYL-(1->2)-ALPHA-L-RHAMNOPYRANOSYL]-(1->2)-BETA-D-XYLOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| The Pagodane Route to Dodecahedranes Directed Conversions – The Pagodane → Bissecododecahedradiene Stage | Chemische Berichte | 1992 |